<DOC>
	<DOCNO>NCT01461746</DOCNO>
	<brief_summary>Previous study suggest addition chemotherapy radiation therapy surgery may survival benefit patient high risk endometrial cancer . In addition , docetaxel plus cisplatin regimen may similar efficacy paclitaxel plus carboplatin currently use case . However , docetaxel plus cisplatin may cause less toxicity compare paclitaxel plus carboplatin . Therefore , investigator aim analyze efficacy docetaxel plus cisplatin regimen follow radiation therapy surgery patient high risk endometrial cancer .</brief_summary>
	<brief_title>Efficacy Study Chemotherapy Followed Radiation Therapy Treat Endometrial Cancer</brief_title>
	<detailed_description />
	<mesh_term>Endometrial Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>One follow high risk group Stage III stag operation Stage II ( Type I hysterectomy + BSO + LND ) Stage I + two [ Grade III , LVSI+ , Mm &gt; 1/2 ] Clear cell serous carcinoma : stage IBII Age : 2075 ECOG PS : 02 Adequate organ function BM : WBC ≥ 3,000/mm3 , ANC≥1,500/mm3 , Plt≥100X103/mm3 , Hb≥10.0 g/dl Kidney : Creatinine &lt; 1.25 × UNL이고 , GFR ≥ 60 Liver : AST , ALT &lt; 3×UNL , T bil &lt; 1.5 mg/ mm3 Informed Consent Previous chemotherapy pelvic RT Hormone therapy within 4 week Other malignant disease Uncontrolled medical disease Infection require antibiotic Symptomatic CHF , RF , Angina , Arrhythmia , etc . Neurosis psychosis Etc .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>